Clinical Trial Update: Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating oprozomib with dexamethasone in combination with lenalidomide or oral cyclophosphamide for newly diagnosed multiple myeloma; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cyclophosphamide (oral) (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Oprozomib (oprozomib)

Snippet

Sponsor: Amgen | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-03-03